{
    "clinical_study": {
        "@rank": "56942", 
        "arm_group": [
            {
                "arm_group_label": "conventional neuromuscular blockade", 
                "arm_group_type": "No Intervention", 
                "description": "No rocuronium will be administered intraoperatively unless there is surgeons' complain or patients movement"
            }, 
            {
                "arm_group_label": "optimal neuromuscular blockade", 
                "arm_group_type": "Active Comparator", 
                "description": "Rocuronium dose will be infused to maintain depth of NMB at TOF count 1 intraoperatively"
            }, 
            {
                "arm_group_label": "profound neuromuscular blockade", 
                "arm_group_type": "Experimental", 
                "description": "Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively"
            }
        ], 
        "brief_summary": {
            "textblock": "Although deep anesthesia can produce skeleton muscle relaxation,unnecessary deep anesthesia\n      often had adverse cardiac effects and was related to 2-year mortality in cancer patients.The\n      use of muscle relaxants allowed the depth of anesthesia to be optimized.However, for many\n      anesthesiologists,in fear of residual postoperative neuromuscular blockade,intraoprative\n      administration of muscle relaxants had to be minimized in spite of poor surgical conditions.\n\n      This study, however, is designed to test the hypothesis that profound neuromusclular\n      blockade reduces muscle trauma caused by self-retaining retractor and thus cut down\n      postoperative analgesic requirement.On the other hand,profound muscle relaxation can\n      decrease postoperative diaphragmatic dysfunction and abdominal muscle trauma, which can\n      improve postoperative pulmonary function."
        }, 
        "brief_title": "Influence of Profound Muscle Relaxation on Muscle Trauma and Postoperative Pulmonary Function", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Profound Muscle Relaxation", 
            "Muscle Trauma", 
            "Postoperative Analgesic Demand", 
            "Postoperative Pulmonary Function"
        ], 
        "condition_browse": {
            "mesh_term": "Wounds and Injuries"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA 1~2,scheduled to undergo upper abdominal surgery by midline incision\n\n        Exclusion Criteria:\n\n          -  neuromuscular disorder\n\n          -  history of malignant hyperthemia\n\n          -  allergy to medications used during general anesthesia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804933", 
            "org_study_id": "\u4f26\u5ba1[2012]326\u53f7"
        }, 
        "intervention": {
            "arm_group_label": [
                "optimal neuromuscular blockade", 
                "profound neuromuscular blockade"
            ], 
            "description": "Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively", 
            "intervention_name": "profound neuromuscular blockade", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "profound muscle relaxation", 
            "muscle trauma", 
            "postoperative analgesic demand", 
            "postoperative pulmonary function"
        ], 
        "lastchanged_date": "March 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510080"
                }, 
                "name": "The First Affiliated Hospital of Sun Yat-sen University"
            }, 
            "investigator": {
                "last_name": "Ying Xiao, MD,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "other_outcome": {
            "description": "FEV1 FVC PEF", 
            "measure": "postoperaive pulmonary function", 
            "safety_issue": "No", 
            "time_frame": "3days postoperatively"
        }, 
        "overall_contact": {
            "email": "xying2603@163.com", 
            "last_name": "Ying Xiao, MD,PhD", 
            "phone": "13570521662"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "last_name": "Ying Xiao, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "serum CK", 
            "measure": "degree of muscle trauma", 
            "safety_issue": "No", 
            "time_frame": "72h postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804933"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "Ying Xiao", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "consumption of morphine", 
            "measure": "postoperative analgesic requirement", 
            "safety_issue": "No", 
            "time_frame": "7days postoperatively"
        }, 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ying Xiao", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}